EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prebiotic, probiotic, and chlorophyllin interventions differentially attenuate melphalan-induced intestinal injury and modulate gut metabolite profiles

Archana Kumari Redhu, Saithang Puia, Nitesh Chavan, Rozma Ali, Abhishek Das, Kshitij Kodolikar, Gourab Das, Sayali Kadam, Kavita Pal, Vikram Gota

Frontiers in Microbiology · 29.10.2026 · 17

DOI: 10.3389/fmicb.2026.2003316 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 29.10.2026. Verfasst von Archana Kumari Redhu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, ACTREC, Tata Memorial Centre, Mumbai, India. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Melphalan treatment can cause substantial gastrointestinal toxicity, yet the relationship between chemotherapy-induced epithelial injury, intestinal barrier dysfunction, and alterations in the gut metabolic environment remains incompletely understood. Here, we investigated whether nutritionally and mechanistically distinct interventions could attenuate melphalan-induced intestinal injury and associated metabolic perturbations.

Methods

C57BL/6 mice were allocated to vehicle control, melphalan alone, melphalan plus fructo-oligosaccharides (FOS), melphalan plus a commercial probiotic preparation containing Lacticaseibacillus paracasei Shirota, or melphalan plus chlorophyllin ( n = per group). Interventions were administered orally for 3 days before and 3 days after a single oral dose of melphalan (10 mg/kg). Intestinal toxicity was characterized through physiological outcomes, circulating markers of epithelial injury and barrier dysfunction, intestinal protein expression, and targeted LC–MS/MS profiling of short-chain fatty acids, bile acids, and indole-derived metabolites.

Results

Melphalan induced body-weight loss and shortening of the small intestine, accompanied by reduced plasma citrulline and increased circulating lipopolysaccharide and occludin, consistent with enterocyte loss and impaired intestinal barrier integrity. These alterations coincided with broad reductions across multiple metabolite classes, indicating substantial disruption of the intestinal metabolic environment. FOS, the commercial probiotic preparation, and chlorophyllin attenuated body-weight loss and restored small-intestinal length and plasma-marker levels toward vehicle-control values. FOS and the probiotic preparation significantly increased selected SCFAs and bile acids, whereas the probiotic preparation and chlorophyllin significantly increased selected tryptophan-derived metabolites. Chlorophyllin also significantly increased taurocholate relative to melphalan alone.

Discussion

These findings support further investigation of gut-directed nutritional interventions as strategies to mitigate chemotherapy-associated intestinal injury, with the exploratory metabolite findings requiring confirmation in larger studies.

Schlagwörter

Stichwörter der Autor:innen

chemotherapy-induced intestinal toxicitychlorophyllinfructo-oligosaccharidesmelphalanprobioticsshort-chain fatty acids

Autor:innen und Institutionen

  • Department of Clinical Pharmacology, ACTREC, Tata Memorial Centre, Mumbai, India.
  • Bioinformatics and Computational Biology, Cancer Research Institute, ACTREC, Tata Memorial Centre, Mumbai, India.
  • Department of Digital & Computational Oncology, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Mumbai, India.
  • Homi Bhabha National Institute, Mumbai, India.

Zitieren

APA

Redhu, A. K., Puia, S., Chavan, N., Ali, R., Das, A., Kodolikar, K., Das, G., Kadam, S., Pal, K., & Gota, V. (2026). Prebiotic, probiotic, and chlorophyllin interventions differentially attenuate melphalan-induced intestinal injury and modulate gut metabolite profiles. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.2003316

Vancouver

Redhu AK, Puia S, Chavan N, Ali R, Das A, Kodolikar K, et al. Prebiotic, probiotic, and chlorophyllin interventions differentially attenuate melphalan-induced intestinal injury and modulate gut metabolite profiles. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.2003316

BibTeX
@article{Redhu2026,
  author = {Redhu, Archana Kumari and Puia, Saithang and Chavan, Nitesh and Ali, Rozma and Das, Abhishek and Kodolikar, Kshitij and Das, Gourab and Kadam, Sayali and Pal, Kavita and Gota, Vikram},
  title = {Prebiotic, probiotic, and chlorophyllin interventions differentially attenuate melphalan-induced intestinal injury and modulate gut metabolite profiles},
  journal = {Frontiers in Microbiology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fmicb.2026.2003316}
}
Kostenlos starten →